Received Jan 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | 1 | Z007201 | — |
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | 2 | Z007201 | — |
Confirmed no symptomatic adverse side effects; The nurse has a 10 year-old patient who received his first dose of RECOMBIVAXHB on 4-DEC-2025 and the 2nd dose accidently too early on 12-DEC-2025.; This spontaneous report was received from a Nurse and refers to a(n) 10-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 04-Dec-2025, the patient was vaccinated with the first dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), lot #Z007201, expiration date: 10-Nov-2027 (exact dose, route of administration and anatomical location were not provided) for prophylaxis On 12-Dec-2025 (too early), the patient was accidently vaccinated with the second dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), lot #Z007201, expiration date: 10-Nov-2027 (exact dose, route of administration and anatomical location were not provided) for prophylaxis (inappropriate schedule of product administration). Confirmed no symptomatic adverse side effects (no adverse event).